US 12,302,934 B2
Nutritional formula
James W. McGrath, Jr., Port Charlotte, FL (US); Paul B. Manning, Troy, VA (US); and Eugene R. Scavola, Charlottesville, VA (US)
Assigned to Building Block Nutritionals, LLC, Charlottesville, VA (US)
Filed by Building Block Nutritionals, LLC, Charlottesville, VA (US)
Filed on Jan. 25, 2023, as Appl. No. 18/159,363.
Application 18/159,363 is a continuation of application No. 17/347,977, filed on Jun. 15, 2021, granted, now 11,606,966.
Claims priority of provisional application 63/039,316, filed on Jun. 15, 2020.
Prior Publication US 2023/0232884 A1, Jul. 27, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A23L 33/00 (2016.01); A23L 2/395 (2006.01); A23L 2/58 (2006.01); A23L 2/60 (2006.01); A23L 2/66 (2006.01); A23L 33/12 (2016.01); A23L 33/125 (2016.01); A23L 33/155 (2016.01); A23L 33/16 (2016.01); A23L 33/19 (2016.01); A61K 9/00 (2006.01); A61K 38/38 (2006.01); A61K 38/40 (2006.01); A61K 47/12 (2006.01); A61K 47/14 (2017.01); A61K 47/26 (2006.01); A61P 3/02 (2006.01)
CPC A23L 33/40 (2016.08) [A23L 2/395 (2013.01); A23L 2/58 (2013.01); A23L 2/60 (2013.01); A23L 2/66 (2013.01); A23L 33/12 (2016.08); A23L 33/125 (2016.08); A23L 33/155 (2016.08); A23L 33/16 (2016.08); A23L 33/19 (2016.08); A61K 9/0095 (2013.01); A61K 38/38 (2013.01); A61K 38/40 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/26 (2013.01); A61P 3/02 (2018.01); A23V 2002/00 (2013.01)] 23 Claims
 
1. A reconstituted, ready-to-use nutritional formula comprising:
a) alpha-lactalbumin enriched whey protein concentrate, wherein the reconstituted, ready-to-use nutritional formula comprises at least 30% alpha-lactalbumin by weight of the alpha-lactalbumin enriched whey protein concentrate;
b) lactoferrin;
c) approximately 1.0 gram to approximately 14.0 grams of oleic acid-palmitic acid-oleic acid triglyceride (OPO triglyceride) per L of the reconstituted, ready-to-use nutritional formula, wherein palmitic acid is at the SN-2 position of the glycerol backbone of the OPO triglyceride;
d) lactose;
e) lutein;
f) docosahexanoic acid;
g) arachidonic acid;
h) approximately 1.0 gram to approximately 8.0 grams of galactooligosaccharides per L of the reconstituted, ready-to-use nutritional formula; and
i) approximately 0.1 grams to approximately 0.5 grams of fructooligosaccharides per L of the reconstituted, ready-to-use nutritional formula;
wherein the reconstituted, ready-to-use nutritional formula does not comprise polydextrose.